Prolonged Hypercoagulability Following Major Liver Resection for Malignancy
Conditions: Hepatic Disease; Surgery-Complications; Hypercoagulability; Thrombosis Interventions: Drug: Redesca (enoxaparin sodium for injection); Drug: Fragmin (dalteparin) Sponsors: Western University, Canada; Valeo Pharma Inc Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Canada Health | Cancer & Oncology | Liver | Lovenox | Pharmaceuticals | Research | Sodium | Thrombosis | Urology & Nephrology